Signal active
Bio
Stephen Kraus, a partner in the Cambridge, Mass. office, has worked with Bessemer since 2004 and focuses on the healthcare sector.
Currently, he focuses his new deal activity on early and growth stage opportunities in healthcare IT and healthcare services. He currently sits on the boards of Liazon, Health Essentials, DocuTAP, Ovascience, Verastem, Allena Pharmaceuticals and Alcresta and is actively involved in BVP's investments in Acceleron and Proteon.
Steve has been actively involved in Bessemer’s investments in Sirtris Pharmaceuticals (NASDAQ: SIRT, acquired by GlaxoSmithKline); Affymax (NASDAQ: AFFY); Aveo (NASDAQ: AVEO); Alnara, acquired by Eli Lilly; Transave (NASDAQ: INSM); Stromedix, acquired by Biogen Idec, Verastem (NASDAQ: VSTM), and Restore Medical (NASDAQ: REST), acquired by Medtronic.
Prior to joining Bessemer, Steve was a director at the Ironwood Equity Fund, a growth-stage, private-equity firm, and a management consultant at Bain & Co. In 2002, he served as speechwriter and operations director for the Democratic nominee for governor of Massachusetts
Steve graduated summa cum laude with a B.A. from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.
He serves on the boards of the New England Venture Capital Association (NEVCA), the Achievement Network, and Interise. Steve was recently recognized by Forbes Magazine as one of the top life science investors if 2013.
Steve regularly blogs with BVP's Ambar Bhattacharyya at HCVC's(two healthcare investors' musings on work and life).
Location
Boston, Massachusetts, United States, North America
Social
Primary Organization
1911
1394
497
306
11-50
Financial Services, Venture Capital, Finance, FinTech, Business Development, Education, InsurTech
Jobs history
2
Mural Health
Board Member
Invalid date - Current
Ginger
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Stephen Kraus is the Partner at Bessemer Venture Partners, based in United States, North America. With a background in Financial Services, Stephen Kraus has a rich history of leadership and innovation. Stephen Kraus studied BA unknown @ Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
16
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jan 07, 2021 | Aspen RxHealth | Series B - Aspen RxHealth | Bessemer Venture Partners | 23.0M |
Oct 12, 2021 | Oshi Health | Series A - Oshi Health | Bessemer Venture Partners | 23.0M |
Feb 28, 2022 | Qventus | Private Equity Round - Qventus | Bessemer Venture Partners | 50.0M |
Sep 19, 2023 | Mural Health | Seed Round - Mural Health | Bessemer Venture Partners | 8.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.